The new project will focus on producing a rhCollagen-based 3D bioprinted human intestine model that will facilitate drug discovery and promote personalized medicine applications for the treatment of ulcerative colitis.
Taking an important step towards bringing greater healthcare equity to the region through medical innovation, Sheba’s ARC Innovation signed an MOU with the New South Wales Government.
Modern medicine has increased life expectancy. However, healthspan expansion has not increased at the same rate due to chronic diseases, including heart disease, stroke, cancer, and dementia.
“This is yet another testament to the hard work of our talented and forward-thinking medical teams,” commented Sheba Director General, Prof. Yitshak Kreiss, shortly upon receiving the news.
Chicago ARC, a newly launched venture in Chicago based on Sheba’s ARC model, aims to bring together health systems, corporations, innovative startups, and community organizations to address health disparities.
In a first-of-its-kind initiative, Sheba representatives joined forces with the U.S. Navy’s 5th Fleet (NAVCENT) to prepare the Kenyan Navy and local healthcare workers for a mass casualty scenario.
